Luis Cristóbal Capitán Morales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luis Cristóbal Capitán Morales has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Javier Valdes-Hernandez
Department of General and Digestive Surgery, University Hospital Virgen Macarena, University of Sevilla, 41009 Sevilla, Spain
7 shared publications - Juan Carlos Gómez-Rosado
Department of General and Digestive Surgery, University Hospital Virgen Macarena, University of Sevilla, 41009 Sevilla, Spain
6 shared publications J Cantillana Martínez
4 shared publicationsE Cabot Ostos
3 shared publicationsFernando Oliva-Mompean
3 shared publicationsJ Loscertales Abril
3 shared publications
Latest Publications
- Open Access
- 23 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4437
Can 3D Imaging Improve Results in Colorectal Cancer Laparoscopic Surgery?
Objective: The aim of this prospective comparative study is to report our experience with 3D laparoscopy in terms of surgeon’s discomfort with 3D vision, and to compare clinical outcomes with 2D laparoscopy in oncological colorectal surgery. Methods: From 2016 to 2017, all consecutive patients who underwent elective colorectal surgery for malignancy were enrolled. Based on surgery, patients were grouped as follows: group A, right hemicolectomy; group B, left hemicolectomy; group C, sigmoidectomy; and group D, anterior resection of the rectum. Results: In total, 171 patients were included, of which 61 were in group A (45 3D and 16 2D), 18 in group B (15 3D and 3 2D), 44 in group C (30 3D and 14 2D) and 48 in group D (36 3D and 12 2D). The surgeon’s discomfort did not occur due to the 3D vision. Complication rate and mean length of hospital stay (LOS) were lower in the 3D group in comparison to 2D, even if without statistically significant differences, in group B (6.6% versus 66.6% and LOS 6.1 ± 5.2 versus 23 ± 21 days), C (6.7% versus 21.4% and LOS 5.9 ± 2.5 versus 9 ± 8.4 days) and D (27.8% versus 50% and LOS 11.9 ± 16 versus 13 ± 11.8 days), respectively. Conclusions: Despite the lack of statistically significant differences between 2D and 3D laparoscopy, this study reports promising trends in favor of 3D laparoscopy, particularly for complex procedures such as anterior resection. Further randomized prospective studies with larger sample sizes and longer follow-up are necessary to conclusively determine the clinical impact of 3D laparoscopy in colorectal surgery.
- 23 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4437
Open AccessCan 3D Imaging Improve Results in Colorectal Cancer Laparoscopic Surgery?
Objective: The aim of this prospective comparative study is to report our experience with 3D laparoscopy in terms of surgeon’s discomfort with 3D vision, and to compare clinical outcomes with 2D laparoscopy in oncological colorectal surgery. Methods: From 2016 to 2017, all consecutive patients who underwent elective colorectal surgery for malignancy were enrolled. Based on surgery, patients were grouped as follows: group A, right hemicolectomy; group B, left hemicolectomy; group C, sigmoidectomy; and group D, anterior resection of the rectum. Results: In total, 171 patients were included, of which 61 were in group A (45 3D and 16 2D), 18 in group B (15 3D and 3 2D), 44 in group C (30 3D and 14 2D) and 48 in group D (36 3D and 12 2D). The surgeon’s discomfort did not occur due to the 3D vision. Complication rate and mean length of hospital stay (LOS) were lower in the 3D group in comparison to 2D, even if without statistically significant differences, in group B (6.6% versus 66.6% and LOS 6.1 ± 5.2 versus 23 ± 21 days), C (6.7% versus 21.4% and LOS 5.9 ± 2.5 versus 9 ± 8.4 days) and D (27.8% versus 50% and LOS 11.9 ± 16 versus 13 ± 11.8 days), respectively. Conclusions: Despite the lack of statistically significant differences between 2D and 3D laparoscopy, this study reports promising trends in favor of 3D laparoscopy, particularly for complex procedures such as anterior resection. Further randomized prospective studies with larger sample sizes and longer follow-up are necessary to conclusively determine the clinical impact of 3D laparoscopy in colorectal surgery.
- 1 January 2023
- Published by Editorial Universidad de Sevilla in Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla
- Vol. 1 (1) , 1-2
Una oportunidad de Innovación.
- 1 January 2023
- Published by Editorial Universidad de Sevilla in Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla
- Vol. 1 (1) , 1-2
Una oportunidad de Innovación.
- Open Access
- 25 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 5924
Human Omental Mesothelial Cells Impart an Immunomodulatory Landscape Impeding B- and T-Cell Activation
Mesothelial cells form the mesothelium, a simple epithelium lining the walls of serous cavities and the surface of visceral organs. Although mesothelial cells are phenotypically well characterized, their immunoregulatory properties remain largely unknown, with only two studies reporting their capacity to inhibit T cells through TGF-β and their consumption of L-arginine by arginase-1. Whether human mesothelial cells can suppress other immune cells and possess additional leukosuppressive mechanisms, remain to be addressed to better delineate their therapeutic potential for cell therapy. Herein, we generated secretomes from omental mesothelial cells (OMC) and assess their capacity to inhibit lymphocytes proliferation, suppress activated T and B cells, as well as to modify macrophage activation markers. The secretome from mesenchymal stromal cells (MSC) served as a control of immuno-suppression. Although OMC and MSC were phenotypically divergent, their cytokine secretion patterns as well as expression of inflammatory and immunomodulary genes were similar. As such, OMC- and MSC-derived secretomes (OMC-S and MSC-S) both polarized RAW 264.7 macrophages towards a M2-like anti-inflammatory phenotype and suppressed mouse and human lymphocytes proliferation. OMC-S displayed a strong ability to suppress mouse- and human-activated CD19+/CD25+ B cells as compared to MSC-S. The lymphosuppressive activity of the OMC-S could be significantly counteracted either by SB-431542, an inhibitor of TGFβ and activin signaling pathways, or with a monoclonal antibody against the TGFβ1, β2, and β3 isoforms. A strong blockade of the OMC-S-mediated lymphosuppressive activity was achieved using L-NMMA, a specific inhibitor of nitric oxide synthase (NOS). Taken together, our results suggest that OMC are potent immunomodulators.
- 25 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 5924
Open AccessHuman Omental Mesothelial Cells Impart an Immunomodulatory Landscape Impeding B- and T-Cell Activation
Mesothelial cells form the mesothelium, a simple epithelium lining the walls of serous cavities and the surface of visceral organs. Although mesothelial cells are phenotypically well characterized, their immunoregulatory properties remain largely unknown, with only two studies reporting their capacity to inhibit T cells through TGF-β and their consumption of L-arginine by arginase-1. Whether human mesothelial cells can suppress other immune cells and possess additional leukosuppressive mechanisms, remain to be addressed to better delineate their therapeutic potential for cell therapy. Herein, we generated secretomes from omental mesothelial cells (OMC) and assess their capacity to inhibit lymphocytes proliferation, suppress activated T and B cells, as well as to modify macrophage activation markers. The secretome from mesenchymal stromal cells (MSC) served as a control of immuno-suppression. Although OMC and MSC were phenotypically divergent, their cytokine secretion patterns as well as expression of inflammatory and immunomodulary genes were similar. As such, OMC- and MSC-derived secretomes (OMC-S and MSC-S) both polarized RAW 264.7 macrophages towards a M2-like anti-inflammatory phenotype and suppressed mouse and human lymphocytes proliferation. OMC-S displayed a strong ability to suppress mouse- and human-activated CD19+/CD25+ B cells as compared to MSC-S. The lymphosuppressive activity of the OMC-S could be significantly counteracted either by SB-431542, an inhibitor of TGFβ and activin signaling pathways, or with a monoclonal antibody against the TGFβ1, β2, and β3 isoforms. A strong blockade of the OMC-S-mediated lymphosuppressive activity was achieved using L-NMMA, a specific inhibitor of nitric oxide synthase (NOS). Taken together, our results suggest that OMC are potent immunomodulators.
- 11 June 2019
- Published by Elsevier in Cirugía Española
- Vol. 97 (7) , 422-423
Réplica a la carta al director «Discrepancias en el análisis de la frecuencia, tipos de complicación y costes económicos en los pacientes ectópicos de cirugía general y digestiva»
- 11 June 2019
- Published by Elsevier in Cirugía Española
- Vol. 97 (7) , 422-423
Réplica a la carta al director «Discrepancias en el análisis de la frecuencia, tipos de complicación y costes económicos en los pacientes ectópicos de cirugía general y digestiva»
- 16 February 2019
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 23 (3) , 279
TAMIS resection of a large colonic polyp 20 cm from the anal verge: could endo-stapling be the solution to peritoneal entry?
- 16 February 2019
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 23 (3) , 279
TAMIS resection of a large colonic polyp 20 cm from the anal verge: could endo-stapling be the solution to peritoneal entry?
- 10 February 2019
- Published by Elsevier in Cirugía Española
- Vol. 97 (5) , 282-288
Análisis de la frecuencia, tipos de complicación y costes económicos en los pacientes ectópicos de cirugía general y digestiva
- 10 February 2019
- Published by Elsevier in Cirugía Española
- Vol. 97 (5) , 282-288
Análisis de la frecuencia, tipos de complicación y costes económicos en los pacientes ectópicos de cirugía general y digestiva
- Open Access
- 26 November 2018
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 22 (11) , 891
TAMIS repair of a rectal stenosis not treatable by endoscopy
- 26 November 2018
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 22 (11) , 891
Open AccessTAMIS repair of a rectal stenosis not treatable by endoscopy
- 1 August 2015
- Published by Elsevier in Cirugía Española
- Vol. 93 (7) , 455-459
Profilaxis de la hernia paraestomal mediante malla de polipropileno en espacio preperitoneal
- 1 August 2015
- Published by Elsevier in Cirugía Española
- Vol. 93 (7) , 455-459
Profilaxis de la hernia paraestomal mediante malla de polipropileno en espacio preperitoneal
- Open Access
- 1 January 2015
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 22 (1) , 19-24
Análisis comparativo de los resultados del uso de neocuerdas frente a la resección de velo posterior en la cirugía reparadora de la insuficiencia mitral degenerativa
- 1 January 2015
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 22 (1) , 19-24
Open AccessAnálisis comparativo de los resultados del uso de neocuerdas frente a la resección de velo posterior en la cirugía reparadora de la insuficiencia mitral degenerativa
- 1 June 2013
- Published by Elsevier in Cirugía Española
- Vol. 91 (6) , 378-383
Importancia de la calidad del informe de alta en la gestión de una unidad clínica quirúrgica
- 1 June 2013
- Published by Elsevier in Cirugía Española
- Vol. 91 (6) , 378-383
Importancia de la calidad del informe de alta en la gestión de una unidad clínica quirúrgica